ASMANEX® HFA (mometasone furoate) Inhalation Aerosol 50
ASMANEX HFA is approved for the maintenance treatment of asthma in patients 5 years and older. ASMANEX HFA will not relieve sudden asthma symptoms and is not for patients under the age of 5 years. ASMANEX HFA is available in 3 dosage strengths, 50 mcg for patients 5 to less than 12 years old, and 100 mcg or 200 mcg for patients 12 years and older.
Actived: 6 days ago